Outclassed: The Battle for Therapeutic Market Share
Andreessen Horowitz
NOVEMBER 16, 2023
We are firmly in the century of biology. The last two decades have seen explosive advancement in biomedical and therapeutic innovations, like the Human Genome Project , the discovery of CRISPR , and the rapid development of Covid-19 mRNA vaccines, to name a few. This rapid innovation has been fueled by an unprecedented amount of investment. Despite the recent slowdown, venture capital investment in the biotech sector in the US ballooned to nearly $25 billion in 2022 from just under $4 billion in
Let's personalize your content